Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.
Source link
About The Author
Wegovy Maker Novo Nordisk Files For FDA Approval of Obesity Drug CagriSema